Shares of Rocket Lab Corp (NASDAQ:RKLB) are trading lower Tuesday morning amid a broader market downturn. The pullback in shares comes as investors look ahead to the company’s third-quarter 2025 financial results, scheduled for release on Nov. 10 after the market close.
- RKLB is among today’s weakest performers. Stay ahead of the curve here.
What To Know: Several momentum stocks are facing selling pressure on Tuesday. The sell-off across the board may be due to weakness in shares of Palantir, despite a strong earnings report from the AI software company. Given the stock’s strong rally into earnings, expectations were very high. Rocket Lab could face a similar bar when it reports next week as the stock has already gained more than 130% year-to-date.
Wall Street is closely watching Rocket Lab leading up to the report, with consensus estimates projecting a loss of 10 cents per share on revenue of approximately $151 million. The subsequent conference call will be monitored for updates on the Neutron rocket’s progress and Space Systems growth.
The stock’s current weakness follows a period of positive momentum in late October after the company announced it had completed a key Systems Integration Review for its LOXSAT mission for NASA and Eta Space, a crucial cryogenic technology demonstration.
The announcement prompted several bullish analyst updates, including a price target hike to $75 from KeyBanc, which maintained its Overweight rating. Baird also initiated coverage with an Outperform rating and a price target of $83.
Benzinga Edge Rankings: Despite Tuesday’s dip, Benzinga Edge rankings show Rocket Lab retains a powerful Momentum score of 98.60 and a positive price trend across short, medium and long-term outlooks.
RKLB Price Action: Rocket Lab shares were down 3.84% at $58.98 at the time of publication on Tuesday, according to Benzinga Pro data.
Read Also: Uber’s Strong Performance Gets Overshadowed By CEOs Robotaxi Comment
How To Buy RKLB Stock
By now you're likely curious about how to participate in the market for Rocket Lab – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
Image: Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

